Transcenta Releases Phase I Clinical Data of TST001 in Combination with CAPOX as the First Line Treatment of Advanced and Metastatic G/GEJ Cancer at ASCO 2022 ...Middle East

SUZHOU, China, June 1, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that clinical...

Hence then, the article about transcenta releases phase i clinical data of tst001 in combination with capox as the first line treatment of advanced and metastatic g gej cancer at asco 2022 was published today ( Thursday 02/06/2022 - 03:28 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Transcenta Releases Phase I Clinical Data of TST001 in Combination with CAPOX as the First Line Treatment of Advanced and Metastatic G/GEJ Cancer at ASCO 2022 )

Also on site :

• ‘The Princess Bride’ Star Cary Elwes Shares Tribute to Rob Reiner: ‘From That Very First Meeting I Fell In Love With Him’
• Passengers stuck on Delta flight for more than two hours after landing at Rochester airport
• A Shockingly Recent Year Just Cracked the Top 5 of Rock's Most Legendary Years